ESUS yields 5.47% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 2
Combined, ESUS + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ESUS + MRK for your $10,000?
ESUS makes a leveraged bullish bet on the MSCI USA ESG Focus Indexan index that holds large- and mid-cap companies exhibiting positive ESG characteristics, while maintaining a market-like risk and return profile. Eligible securities are initially screened to exclude firms involved in tobacco, controversial weapons, fossil fuel extraction, and thermal coal power. The portfolio is then optimized to maximize its exposure to ESG factors while staying true to a market-like exposure (subject to constraints). The underlying index rebalances quarterly. As a levered product with 2x factor that resets quarterly, the fund is not a buy-and-hold investment and should not be expected to provide index leverage return on a day-to-day basis. In addition, investors should note that ESUS is an ETN, and therefore carries the credit risk of the issuer, UBS.
Full ESUS Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.